Abstract
Background:
Existing evidence regarding the impact of the COVID-19 pandemic on postpartum mental health is mixed, with disparate studies showing increased, stable, or even reduced risk of postpartum depression (PPD) amid the pandemic. Furthermore, although it is plausible that the pandemic impacted the mental health of mothers from vulnerable and underserved communities differentially, few studies have characterized racial and ethnic differences in the impact of the COVID-19 pandemic on PPD.
Materials and Methods:
Pregnancy Risk Assessment Monitoring System data for 2018–2019 (pre-pandemic period) and 2020 (peri-pandemic period) from 40 sites (n = 110,779, representing 5,485,137 postpartum women) were used to determine whether rates of PPD changed during the first year of the pandemic. Postpartum depressive symptoms were assessed using the Patient Health Questionnaire 2-item. Average marginal effects and contrasts of predictive margins derived from a multivariable logistic regression model were used to compare the risk of PPD before and during the pandemic in the overall sample and across racial/ethnic subgroups.
Results:
Adjusting for sociodemographic and clinical characteristics, we found that the overall risk for PPD remained stable (0.0 percentage points [pp]; 95% confidence interval [CI]: −0.7, 0.6 pp) in the first year of the pandemic. We detected no statistically significant changes in risk for PPD across seven of eight racial/ethnic groups considered; however, the risk of PPD among non-Hispanic Black women fell by 2.0 pp (95% CI: −3.5, −0.4 pp) relative to the pre-pandemic period.
Conclusion:
We identified important subgroup differences in pandemic-related changes in risk for PPD.
Introduction
Postpartum depression (PPD) is the most common morbidity following childbirth. 1,2 The condition, characterized by symptoms of depressed mood, loss of interest or pleasure, and feelings of worthlessness, can arise at any point during the first year following birth. 1 Without intervention, symptoms may persist for years. 3 Failure to detect or treat PPD compromises maternal and child well-being; consequences can include relational difficulties, deliberate self-harm, and suicide. 4
In the United States, postpartum depressive symptoms (PPDS) declined between 2004 and 2018, with a prevalence of 13.2% in 2018. 5,6 However, the COVID-19 pandemic dramatically altered health care delivery, increasing barriers to preventive postpartum health care services, 7,8 and the treatment of maternal mental health disorders. 9 Pandemic-related changes in day-to-day activities, unemployment, financial difficulties, fears, and social isolation may have further impacted postpartum mental health. 10 A systematic review on PPD during the COVID-19 pandemic reported a prevalence rate range of 7.0–80%. 11 Although some studies have reported an increased prevalence of PPDS during the COVID-19 pandemic, 7,12 –14 several studies have found that the risk of PPD was unchanged or reduced relative to the pre-pandemic period. 15 –18 Some have noted the potentially positive effects of expanded availability of virtual mental health services, improved postpartum bonding, and increased duration of leave for mothers postdelivery during the pandemic. 15,17,19
Most prior research on changes in PPDS during the COVID-19 pandemic has been based on analyses of convenience samples, 20 clinical data, 7,12,15 or state-level administrative data sources (e.g., vital statistics) 13 or surveillance data. 14 Evidence based on larger, more diverse samples is needed to increase generalizability and draw conclusions based on subgroup analyses. Given the persistent racial and ethnic disparities in maternal morbidity and mortality in the United States and the disproportionate burden of COVID-19 borne by communities of color, it is plausible that the COVID-19 pandemic impacted the mental health of mothers from vulnerable and underserved communities differentially. 8,21 –25 Yet, to our knowledge, pandemic-related changes in racial and ethnic disparities in PPDS are yet to be explored in a large, diverse sample.
In the present study, we used population-based surveillance data for 40 sites that participate in the Centers for Disease Control and Prevention (CDC) Pregnancy Risk Assessment Monitoring System (PRAMS) surveillance project to (1) determine how the prevalence of PPDS changed during the first year of the pandemic compared to the pre-pandemic period and (2) examine to what extent pandemic-related changes in PPDS varied by race and ethnicity.
Materials and Methods
Data source and study participants
This study utilized repeated cross-sectional data from the 2018–2020 PRAMS, a population-based surveillance system that collects data related to pre-conception, prenatal and postpartum care. The PRAMS study protocol and survey methodology were developed by the CDC. The survey is administered by state and local health departments to women who gave birth within the previous 2–6 months. 26 Details on PRAMS survey methodology have been described previously. 27
We received data from PRAMS sites and surveys that met the CDC’s 50% response rate threshold. Sites located in U.S. territories (Puerto Rico) were excluded. We further restricted the sample to sites with PRAMS data available for both the pre-pandemic (2018 and/or 2019) and peri-pandemic (2020) periods. Six sites that had data available for the pre-pandemic period only (IN, NC, NY, OK, RI) or the peri-pandemic period only (AZ) were excluded. Our study sample comprised a total of 40 PRAMS sites, including 38 states (AK, AL, AR, CO, CT, DE, FL, GA, HI, IA, IL, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, ND, NE, NH, NJ, NM, OR, PA, SD, TN, UT, VA, VT, WA, WI, WV, WY), the District of Columbia, and New York City. After excluding sites that did not meet sample inclusion criteria (described earlier) and records with missing data (see Supplementary Table S1 for a summary of variable missingness), we obtained a final sample of 110,779 postnatal women. The University of South Carolina Institutional Review Board determined the study was exempt from review because it involved secondary analysis of publicly available, de-identified data.
Measures
Dependent variable
Self-reported PPDS were assessed via a modified version of the Patient Health Questionnaire 2-item (PHQ-2) included in the PRAMS questionnaire. This screening tool consists of two questions: (1) “Since your new baby was born, how often have you felt down, depressed, or hopeless?” and (2) “Since your new baby was born, how often have you had little interest or little pleasure in doing things you usually enjoyed?”. Response options include “always,” “often,” “sometimes,” “rarely,” and “never.” Respondents who answered “always” or “often” to either question were classified as experiencing PPDS. Respondents who answered “sometimes,” “rarely,” or “never” to both questions were classified as not having PPDS. 28,29
Independent variable
The COVID-19 pandemic period was categorized as pre-pandemic (2018–2019) or peri-pandemic (2020).
Covariates
Covariate selection was guided by Andersen’s behavioral model and the variables available in the 2018–2020 PRAMS surveys and linked birth certificates. 30
Race and ethnicity data were obtained from the linked birth certificate. In our analyses, maternal race/ethnicity was categorized as Hispanic, non-Hispanic (NH) American Indian and Alaska Native (AIAN), NH Asian and Native Hawaiian and Pacific Islander (Asian/NHPI), NH Black, NH White (ref), other/mixed, or unknown (Supplementary Table S2). Other covariates derived from the birth certificate included maternal age (<20, 20–29 [ref], or ≥30 years), educational attainment (less than high school, high school graduate, or college graduate [ref]), marital status (married [ref] or unmarried), receipt of Special Supplemental Nutrition Program for Women, Infants and Children (WIC) benefits during pregnancy (yes or no [ref]), smoking during pregnancy (yes or no [ref]), diabetes during pregnancy (yes or no [ref]), hypertension during pregnancy (yes or no [ref]), whether the infant was living at time of report (yes [ref] or no), whether the infant was born with a birth defect (yes or no [ref]), vaginal delivery (yes [ref] or no), preterm birth (yes or no [ref]; preterm birth defined as birth at <37 weeks gestation), and low birth weight (yes or no [ref]; low birth weight defined as birth weight <2,500 g).
Covariates derived from the PRAMS survey included depression during the 3 months before pregnancy (yes or no [ref]), whether the pregnancy was intended (yes [ref] or no; pregnancies were classified as “intended” if wanted “then” or “sooner” 31,32 ), and current health insurance coverage (yes or no [ref]).
Region of residence (Midwest, Northeast [ref], South, or West census region) was assigned using information on the location of PRAMS sites.
Statistical analysis
Descriptive statistics, including frequencies (unweighted) and percentages (weighted) with 95% confidence intervals (CI), were calculated to describe the study sample. Furthermore, we compared the distribution of maternal and infant characteristics across PPDS status. The Rao-Scott chi-square test was used to determine the statistical significance of bivariate associations. Multivariable logistic regression was used to examine the association between giving birth during the peri-pandemic period and PPDS. The regression model included the covariates described earlier and interactions between race/ethnicity and COVID-19 pandemic period. Results from this nonlinear model were reported as average marginal effects (AME) to understand how a change in a risk factor (e.g., delivering in the peri-pandemic versus the pre-pandemic period) affects the predicted probability of experiencing PPDS, holding other covariates constant. 33 –35 Next, to facilitate interpretation of the interaction effects, for each category of race/ethnicity, we compared the predicted probabilities of experiencing PPDS in the peri-pandemic and pre-pandemic periods. 34 The contrast (i.e., the difference in the predicted probability for the peri-pandemic versus the pre-pandemic period) allowed us to assess whether the association between COVID-19 pandemic period and PPDS varied according to race/ethnicity. Analyses were conducted using the survey commands in Stata, version 16 (StataCorp LLC) to apply sampling weights provided by the PRAMS. Estimates were considered statistically significant if 95% CI did not include 0 (equivalent to a two-sided p < 0.05).
Results
Sample characteristics
The study population included 110,779 women (Table 1). Of those, 73,948 gave birth in the pre-pandemic period (2018–2019 PRAMS sample) and 36,831 delivered in the peri-pandemic period (2020 PRAMS sample). The sample was racially and ethnically diverse; 16.7% of sample women were Hispanic, 0.7% NH AIAN, 5.2% NH Asian/NHPI, 15.7% NH Black, 57.8% NH White, and 3.1% other/mixed race. Overall, the highest proportion of sample women were aged ≥30 years (49.2%), high school graduates (51.7%), married (61.9%), and residents of states in the South census region (36.5%). Around 15% of sample women reported having depression in the 3 months before they got pregnant (15.1%). Close to two-thirds did not receive WIC during pregnancy (67.3%), and most reported not smoking during pregnancy (93.4%). Rates of diabetes and hypertension during pregnancy were 7.3% and 10.5%, respectively. Close to two-thirds of sample women had a vaginal delivery (67.1%). Nearly all had current health insurance coverage (90.7%). Among infants, the prevalence of preterm birth, low birth weight, and birth defects was 9.0%, 7.2%, and 0.2%, respectively.
Characteristics of Women With and Without Postpartum Depressive Symptoms; 40 PRAMS Sites, 2018–2020 a
The sample was restricted to 40 PRAMS sites with data available for both the pre-pandemic and peri-pandemic periods: AK, AL, AR, CO, CT, DC, DE, FL, GA, HI, IA, IL, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, ND, NE, NH, NJ, NM, NYC, OR, PA, SD, TN, UT, VA, VT, WA, WI, WV, WY.
Unweighted frequency.
Weighted prevalence and 95% CI.
Preterm birth is defined as birth at <37 weeks gestation.
Low birth weight is defined as birth weight <2,500 g.
Pregnancies were classified as intended when a respondent indicated that she wanted to be pregnant “then” or “sooner.”
AIAN, American Indian and Alaska Native; CI, confidence interval; NHPI, Native Hawaiian and Pacific Islander; PRAMS, Pregnancy Risk Assessment Monitoring System; WIC, women, infants and children nutrition program.
Prevalence of PPDS
The overall prevalence of PPDS was 13.4% (95% CI:13.1–13.7%). Similar prevalence rates were found in the peri-pandemic (13.4%; 95% CI: 12.9–14.0%) and pre-pandemic (13.4%; 95% CI: 13.0–13.7%) periods. Bivariate comparisons revealed significantly higher prevalence of PPDS among mothers who reported depression in the 3 months before pregnancy (29.8%; 95% CI: 28.7–30.9%; p < 0.001), were aged <20 years (22.3%; 95% CI: 20.4–24.4%; p < 0.001), unmarried (17.5%; 95% CI: 16.9–18.1%; p < 0.001), and did not complete high school (16.8%; 95% CI: 15.7–18.0%; p < 0.001). Higher rates of PPDS were also noted among NH AIAN (19.5%; 95% CI: 17.3–21.9%), NH Black (18.1%; 95% CI: 17.2–19.0%), and NH Asian/NHPI (17.9%; 95% CI: 16.6–19.4%; p < 0.001) mothers.
Associations between PPDS, COVID-19 pandemic, and maternal and infant characteristics
The AME presented in Table 2 show how a change in a risk factor affects the predicted probability of experiencing PPDS, holding other covariates constant. After adjusting for maternal and infant characteristics, we found no relationship between the COVID-19 pandemic and PPDS (AME: 0.00 percentage points [pp]; 95% CI: −0.7, 0.8 pp; p = 0.943). Compared with those aged 20–29 years, younger women aged <20 years were more likely to experience PPDS (AME: 3.1 pp; 95% CI: 1.3, 4.8 pp), whereas women aged ≥30 years were less likely to experience PPDS (AME: −2.2 pp; 95% CI: −2.9, −1.5 pp). Compared with NH White women, the predicted probability of experiencing PPDS was significantly higher among NH AIAN (AME: 3.8 pp; 95% CI: 1.8, 5.8 pp) Asian/NHPI (AME: 11.4 pp; 95% CI: 9.6, 13.1 pp), Black (AME: 3.7 pp; 95% CI: 2.7, 4.7 pp), and other/mixed race (AME: 3.9 pp; 95% CI: 2.1, 5.8 pp) women. Compared with women residing in the Northeast census region, women residing in the South (AME: 2.0 pp; 95% CI: 1.1, 3.0 pp) were more likely to experience PPDS.
AME derived from logistic regression model that included the covariates listed earlier and interactions between COVID-19 pandemic period and race/ethnicity. Predicted probabilities and contrasts related to the interaction effects are presented in Table 3.
The sample was restricted to 40 PRAMS sites with data available for both the pre-pandemic and peri-pandemic periods: AK, AL, AR, CO, CT, DC, DE, FL, GA, HI, IA, IL, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, ND, NE, NH, NJ, NM, NYC, OR, PA, SD, TN, UT, VA, VT, WA, WI, WV, WY.
Preterm birth is defined as birth at <37 weeks gestation.
Low birth weight is defined as birth weight <2,500 g.
Pregnancies were classified as intended when a respondent indicated that she wanted to be pregnant “then” or “sooner”.
AIAN, American Indian and Alaska Native; AME, Average Marginal Effect; CI, confidence interval; NHPI, Native Hawaiian and Pacific Islander; PRAMS, Pregnancy Risk Assessment Monitoring System; Ref., Reference Category; WIC, women, infants and children nutrition program.
Predicted probabilities and contrasts derived from logistic regression model that included interactions between COVID-19 pandemic period and race/ethnicity. Average marginal effects for the remaining covariates are presented in Table 2.
The sample was restricted to 40 PRAMS sites with data available for both the pre-pandemic and peri-pandemic periods: AK, AL, AR, CO, CT, DC, DE, FL, GA, HI, IA, IL, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, ND, NE, NH, NJ, NM, NYC, OR, PA, SD, TN, UT, VA, VT, WA, WI, WV, WY.
AIAN, American Indian and Alaska Native; CI, confidence interval; NHPI, Native Hawaiian and Pacific Islander; PRAMS, Pregnancy Risk Assessment Monitoring System.
Associations between PPDS and COVID-19 pandemic by maternal race/ethnicity
In Table 3, we present the predicted probabilities of experiencing PPDS in the peri-pandemic and pre-pandemic periods for each category of race/ethnicity. The contrast allows us to assess to what extent the association between COVID-19 pandemic period and PPDS may vary according to maternal race/ethnicity. Among NH Black women, the predicted probability of experiencing PPDS decreased by 2.0 pp in the peri-pandemic period relative to the pre-pandemic period (95% CI: −3.5, −0.4 pp; p = 0.012). We observed a similar decrease in the probability of PPDS among NH Asian/NHPI women (contrast: −1.8 pp; 95% CI: −5.3, 1.6 pp; p = 0.296); however, the contrast was not statistically significant at the 95% level. In other groups, we observed small but statistically insignificant increases in the probability of PPDS in the peri-pandemic period.
Sensitivity Analyses
Study findings were insensitive to the exclusion of records with unknown race/ethnicity (Supplementary Table S3), alternative treatments of births in January–March 2020 (Supplementary Table S4), using different controls for geographic variation in PPDS (Supplementary Table S5), and using different controls for health insurance coverage (Supplementary Table S6). Overall patterns were similar when the sample was further restricted to sites with PRAMS data available for each of the three years in our sample period (Supplementary Table S7). Finally, we split the peri-pandemic period into “early” (January–June 2020) and “late” (July–December 2020) stages in order to explore how changes in PPDS may have evolved over the course of the first year of the pandemic (Supplementary Table S8). Among NH Black women, estimated contrasts were similar across the early and late stages of the peri-pandemic period. We detected no statistically significant changes in risk of PPDS for the remaining categories of maternal race/ethnicity.
Discussion
This study, based on a geographically, racially, and ethnically diverse sample of U.S. women, found no association between giving birth during the COVID-19 pandemic and PPDS for most women after adjusting for maternal and infant characteristics. Although some prior work points to an increased prevalence PPDS during the COVID-19 pandemic, 7,12 –14 our findings are consistent with several studies that suggest that the risk of PPD remained stable or fell during the pandemic. 15 –18 It is possible that, for most women, pandemic-related disruptions to health systems and social life were offset by the benefits of expanded availability of virtual mental health services, improved postpartum bonding, and increased duration of leave for mothers postdelivery during the pandemic. 15,17,19 In an analysis of vital statistics data for births in the central region of New Jersey, McFarland et al. reported higher levels of PPD among women who gave birth in the first month of the pandemic (March 2020). 13 However, giving birth during the second month of the pandemic was unrelated to PPDS, suggesting that with additional time and information (and reduced uncertainty), women were able to adapt and cope with pandemic stressors. 13 Federal COVID-19 relief assistance programs may have further contributed to resilience. 36,37
The null association in the overall sample masked important subgroup heterogeneity. Across most of the racial/ethnic groups considered, weakly positive associations between the COVID-19 pandemic period and the likelihood of experiencing PPDS were small in magnitude and statistically insignificant. In contrast, we found that the prevalence of PPDS among NH Black women decreased by 2.0 pp during the peri-pandemic period. A similar decrease was found among NH Asian/NHPI women, though we could not rule out a null association. We had hypothesized that the incidence of PPDS would increase within minoritized populations, similar to patterns observed for other natural disasters. 38 Nonetheless, our findings are consistent with prior work examining changes in prenatal mood among low-income pregnant women during the COVID-19 pandemic that found depression symptomatology among minority women declined. 16 This observation may be attributed to higher levels of self-reliance, 39 emotion regulation, 39 and resilience 40,41 among NH Black women or, potentially, unexpected positive effects of pandemic-related social restrictions. 16 Further research to elucidate the underlying mechanisms will be essential.
PPDS were prevalent before and during the COVID-19 pandemic. The estimated prevalence rates in our sample, 13.4% in both the pre-pandemic and the peri-pandemic period, were higher than those reported in another U.S.-based study (6.5% and 6.9%, respectively). 20 The adoption of a validated and more sensitive tool for the detection of PPDS in the CDC PRAMS could account for some of the observed differences. In addition, the earlier study was limited to mothers who downloaded and utilized a mobile health application. Thus, it is possible that mothers with better digital access, more education, and higher socioeconomic status were overrepresented in the sample and contributed to an underestimation of PPDS. In contrast, a prevalence rate of 75% was reported for convenience sample of 262 postpartum women living in the United States during the pandemic. 42 The authors attributed the high prevalence to the application of a highly sensitive tool in detecting PPD and the fact that about one-third of the women had a prior history of depression. The use of snowball sampling in recruiting participants could have led to a homogenous study population and further contributed to overstatement of the prevalence of PPDS.
Throughout the 2018–2020 study period, PPDS were more prevalent among NH women from minoritized groups than among NH White women. Furthermore, NH Asian/NHPI mothers had the highest probability of experiencing PPDS in the multivariable analysis. Unlike previous studies that noted poorer maternal health outcomes in Hispanic mothers, 8,43 we found no significant difference in the prevalence of PPDS among Hispanic compared with NH White mothers. We are unclear about the possible reasons for this disparity; nonetheless, our findings highlight the need to redouble efforts aimed at reducing the burden of PPD and the ongoing need for interventions to mitigate racial inequities in maternal mental health.
Our study has several limitations that should be noted. First, PPDS are self-reported in the PRAMS, which could lead to response bias. However, the PHQ-2 screening tool has been shown to be valid and reliable. 44 Second, associations cannot be interpreted causally owing to the pooled cross-sectional nature of the study. The aim of this study was to document changes in PPDS during the first year of the COVID-19 pandemic. Moving forward, our study findings, based on data for women who gave birth in 2020, should be extended by incorporating more recent data from 2021 and beyond. Future studies should explore the roles of prenatal care, 45,46 postpartum care, 47 social support, 48 experiences of systemic and interpersonal racism, 29,49,50 and other stressors 51,52 in understanding the potential mechanisms underlying the subgroup differences.
Conclusion
Although this study found no change in PPDS during the COVID-19 pandemic for most women, the null association in the overall sample masked important subgroup differences. Among NH Black women, the probability of PPDS fell by 2.0 percentage points in the peri-pandemic period compared with the pre-pandemic period. Irrespective of the pandemic period, we observed a disproportionate burden of PPDS among NH women who identified as AIAN, Asian/NHPI, Black, or other/mixed race, highlighting an ongoing need for public health strategies aimed at promoting racial/ethnic equity in maternal mental health.
Footnotes
Acknowledgment
The authors would like to acknowledge the PRAMS Working Group and the CDC.
Authors’ Contribution
I.N.O.: Conceptualization; Formal analysis; Data Curation; Writing - Original Draft; Writing - Review & Editing; Visualization. N.L.H.: Conceptualization; Methodology; Validation; Writing - Review & Editing. B.C.: Conceptualization; Methodology; Writing - Review & Editing. P.H.: Conceptualization; Methodology; Writing - Review & Editing.
Author Disclosure Statement
No competing financial interests exist.
Funding Information
No funding was received for this article.
Supplementary Material
Supplementary Table S1
Supplementary Table S2
Supplementary Table S3
Supplementary Table S4
Supplementary Table S5
Supplementary Table S6
Supplementary Table S7
Supplementary Table S8
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
